Published in Pediatr Res on October 01, 1998
Velo-cardio-facial syndrome: 30 Years of study. Dev Disabil Res Rev (2008) 2.44
Thrombocytopenias: a clinical point of view. Blood Transfus (2009) 0.86
Low platelet count in a 22q11 deletion syndrome subtype of schizophrenia. Schizophr Res (2001) 0.85
Frequency of thrombocytopenia and large platelets correlates neither with conotruncal cardiac anomalies nor immunological features in the chromosome 22q11.2 deletion syndrome. Eur J Pediatr (2004) 0.85
Hematological abnormalities and 22q11.2 deletion syndrome. Rev Bras Hematol Hemoter (2011) 0.82
Effect of 22q11.2 deletion on bleeding and transfusion utilization in children with congenital heart disease undergoing cardiac surgery. Pediatr Res (2015) 0.75
Thrombocytopenia and Postpartum Hemorrhage in a Woman with Chromosome 22q11.2 Deletion Syndrome. Case Rep Obstet Gynecol (2016) 0.75
Passage of inhaled particles into the blood circulation in humans. Circulation (2002) 5.97
Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet (2006) 3.70
Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet (2008) 3.35
Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med (2001) 3.34
Anticoagulants and spinal-epidural anesthesia. Anesth Analg (1994) 3.17
A toddler with Down syndrome, hypercalcaemia, hypercalciuria, medullary nephrocalcinosis and renal failure. Pediatr Nephrol (1995) 3.12
Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet (1981) 2.81
GATA3 haplo-insufficiency causes human HDR syndrome. Nature (2000) 2.73
von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen. J Thromb Haemost (2006) 2.33
Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet (1997) 2.20
The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet (1998) 2.16
Major coagulation disturbances during fractionated plasma separation and adsorption. Am J Transplant (2007) 1.97
Transapical left ventricular access for difficult to reach interventional targets in the left heart. Catheter Cardiovasc Interv (2009) 1.89
Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet (2000) 1.86
Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. Hum Mol Genet (2001) 1.84
Thromboxane synthetase inhibition as antithrombotic strategy. Lancet (1981) 1.82
Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III. Am J Hum Genet (2000) 1.80
Thrombolytic therapy with streptokinase using a standard dosage scheme. Br Med J (1966) 1.75
Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring. Neurology (2003) 1.67
Alagille syndrome (arteriohepatic dysplasia) and del(20)(p11.2) Am J Med Genet (1990) 1.61
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Delineation of the critical deletion region for congenital heart defects, on chromosome 8p23.1. Am J Hum Genet (1999) 1.56
A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate. Thromb Haemost (1993) 1.56
Mild Wolf-Hirschhorn syndrome: micro-array CGH analysis of atypical 4p16.3 deletions enables refinement of the genotype-phenotype map. J Med Genet (2004) 1.55
RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions. J Med Genet (2005) 1.52
Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. Am J Med Genet (2000) 1.49
Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood (2001) 1.47
Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase. Circulation (1995) 1.47
Cardiorespiratory exercise function after the arterial switch operation for transposition of the great arteries. Eur Heart J (2001) 1.44
Hypoplastic claviculae in the Kabuki (Niikawa-Kuroki) syndrome. Genet Couns (1998) 1.43
Intravascular coagulation in liver disease. Annu Rev Med (1974) 1.40
A double blind study of the effect of tranexamic acid in essential menorrhagia. Thromb Diath Haemorrh (1968) 1.38
Intellectual abilities in a large sample of children with Velo-Cardio-Facial Syndrome: an update. J Intellect Disabil Res (2007) 1.37
Platelet aggregation in whole blood--studies with a platelet counting technique--methodological aspects and some applications. Thromb Haemost (1989) 1.37
The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet Couns (1999) 1.36
Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N Engl J Med (1998) 1.35
Genotype-phenotype correlation in 21 patients with Wolf-Hirschhorn syndrome using high resolution array comparative genome hybridisation (CGH). J Med Genet (2007) 1.32
Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J Biol Chem (1992) 1.32
A balanced translocation t(6;14)(q25.3;q13.2) leading to reciprocal fusion transcripts in a patient with intellectual disability and agenesis of corpus callosum. Cytogenet Genome Res (2010) 1.31
Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. Am J Hum Genet (1997) 1.29
PA26 is a candidate gene for heterotaxia in humans: identification of a novel PA26-related gene family in human and mouse. Hum Genet (2003) 1.23
Nonisotopic quantitative analysis of protein-DNA interactions at equilibrium. Anal Biochem (1997) 1.22
Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor. Blood (1998) 1.22
Aarskog-Scott syndrome: clinical update and report of nine novel mutations of the FGD1 gene. Am J Med Genet A (2010) 1.21
Isolated supravalvular aortic stenosis: functional haploinsufficiency of the elastin gene as a result of nonsense-mediated decay. Hum Genet (2000) 1.20
Neuropsychological, learning and psychosocial profile of primary school aged children with the velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability? Child Neuropsychol (1999) 1.20
Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. Hum Mutat (2008) 1.20
Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction. Blood (1993) 1.19
Plasma 6-keto-PGF1 alpha levels after plasma exchange in thrombotic thrombocytopenic purpura. Lancet (1980) 1.19
The neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism. J Med Genet (2003) 1.19
Primary, nonsyndromic vesicoureteric reflux and its nephropathy is genetically heterogeneous, with a locus on chromosome 1. Am J Hum Genet (2000) 1.18
Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol (1982) 1.16
Dysfibrinogenaemia associated with primary hepatoma. Scand J Haematol (1972) 1.16
Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure. J Pediatr (2000) 1.14
Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid. Biochim Biophys Acta (1974) 1.14
"Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol (1981) 1.14
Dipyridamole inhibits platelet aggregation in whole blood. Thromb Haemost (1983) 1.13
Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo? Ann Oncol (1999) 1.13
Self expandable stents for relief of venous baffle obstruction after the Mustard operation. Heart (1998) 1.13
Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation (1994) 1.13
Rearrangement of the human CDC5L gene by a t(6;19)(p21;q13.1) in a patient with multicystic renal dysplasia. Genomics (1998) 1.12
A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2. Thromb Res (1982) 1.12
Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress. Blood (1999) 1.10
The prevalence of PAX2 mutations in patients with isolated colobomas or colobomas associated with urogenital anomalies. J Med Genet (1998) 1.10
Improved agarose electrophoretic method for separating alkaline phosphatase isoenzymes in serum. Clin Chem (1988) 1.09
Renal and urological tract malformations caused by a 22q11 deletion. J Med Genet (1996) 1.08
Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis. Hum Genet (2001) 1.08
Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders. Trends Pharmacol Sci (1991) 1.08
More on: uncertain times for research on hemophilia and allied disorders. J Thromb Haemost (2005) 1.07
Outcome of recent thromboembolic occlusions of limb arteries treated with streptokinase. Br Med J (1970) 1.07
Molecular analysis of SALL1 mutations in Townes-Brocks syndrome. Am J Hum Genet (1999) 1.07
Platelet activation. Blood Rev (1995) 1.06
Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells. J Med Virol (1994) 1.05
Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate. Thromb Haemost (1997) 1.05
A novel MSX1 mutation in hypodontia. Am J Med Genet A (2004) 1.04
Challenges of interpreting copy number variation in syndromic and non-syndromic congenital heart defects. Cytogenet Genome Res (2011) 1.04
Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development. Circ Res (2001) 1.04
Regional localization of two genes for nonspecific X-linked mental retardation to Xp22.3-p22.2 (MRX49) and Xp11.3-p11.21 (MRX50). Am J Med Genet (1997) 1.04
The evolving role of thrombospondin-1 in hemostasis and vascular biology. Cell Mol Life Sci (2008) 1.03
Variable phenotype in Greig cephalopolysyndactyly syndrome: clinical and radiological findings in 4 independent families and 3 sporadic cases with identified GLI3 mutations. Am J Med Genet A (2003) 1.02
Neuropsychopathology in 7 Patients with the 22q13 Deletion Syndrome: Presence of Bipolar Disorder and Progressive Loss of Skills. Mol Syndromol (2012) 1.02
Psychotic disorders in Prader-Willi syndrome. Am J Med Genet A (2004) 1.00
The incidence of a deletion in chromosome 22Q11 in sporadic and familial conotruncal heart disease. Eur J Pediatr (1996) 1.00
Transcription factor GATA3 and the human HDR syndrome. Cell Mol Life Sci (2001) 1.00
Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele. J Clin Invest (1995) 1.00
Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis. Rev Eur Etud Clin Biol (1970) 1.00
A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor. Blood (2000) 1.00
The current state of clinical ethics and healthcare ethics committees in Belgium. J Med Ethics (2005) 1.00
Acute hepatitis A in patients with haemophilia A. Lancet (1993) 0.99
Co-cultures of multiple cell types mimic pulmonary cell communication in response to urban PM10. Eur Respir J (2008) 0.99
The t(4;8) is mediated by homologous recombination between olfactory receptor gene clusters, but other 4p16 translocations occur at random. Genet Couns (2007) 0.98